Results 31 to 40 of about 1,385 (194)

Expert Perspective: Diagnosis and Treatment of Castleman Disease. [PDF]

Arthritis Rheumatol
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Chen LYC, Zhang L, Fajgenbaum DC.
europepmc   +2 more sources

Concurrence of Marjolin’s Ulcer in the Lower Limb in a Patient with Idiopathic Multicentric Castleman Disease: A Case Report

Medicina, 2022
Idiopathic multicentric Castleman disease (iMCD) is characterized by the benign proliferation of lymphoid cells in multiple regions. However, the co-occurrence of epithelial malignancy and idiopathic multicentric Castleman disease (iMCD) is rarely ...
Ping-Ruey Chou, Kun-Bow Tsai, Chao-Wei Chang, Tzu-Yu Lin, Yur-Ren Kuo   +4 more
doaj   +1 more source

Heterogeneous Presentations of iMCD: A Single-Institution Case Series. [PDF]

Case Rep Hematol
Background Idiopathic multicentric Castleman disease (iMCD) is a rare lymphadenopathic disorder characterized by hyperplasia of multiple lymph nodes and can be associated with a wide range of symptoms and presentations, from mild disease to life‐threatening organ failure.
Kaur J, Sisk A, Zuckerman JE, Abdulhaq H.   +3 more
europepmc   +2 more sources

A Rare Association between Idiopathic Multicentric Castleman Disease, Nephrotic Syndrome and Polyneuropathy in an immunocompetent patient

European Journal of Case Reports in Internal Medicine, 2021
Multicentric Castleman disease (MCD) represents a group of poorly understood lymphoproliferative disorders related to proinflammatory hypercytokinaemia.
Luís Landeiro, Ana Carolina Freitas, Margarida Proença, José Cabeçadas, Albertina Nunes, Alexandra Bayão Horta   +5 more
doaj   +1 more source

Historical and pathological overview of Castleman disease [PDF]

, 2022
Castleman disease consists of several lymphoproliferative subtypes that share some histological features in the lymph nodes. On the other hand, numerous clinical findings and etiologies make the disease challenging to understand.
Nishikori, Asami, Nishimura, Midori Filiz, Nishimura, Yoshito, Sato, Yasuharu, Yoshino, Tadashi   +4 more
core   +1 more source

Idiopathic multicentric Castleman disease: a mysterious case of generalized lymphadenopathy [PDF]

, 2023
Castleman disease is a syndrome with significant clinico-pathological overlap between malignancy, autoimmune causes and infectious etiologies.
J., Kumanan, Lakshmanan, Archana, P. N., Shoaib Nawaz, Raja, Thirumalairaj, Ramya Ananthkrishnan, Sebastian, Nikhil   +5 more
core   +2 more sources

Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease? [PDF]

, 2022
Idiopathic multicentric Castleman disease (iMCD) is a systemic disorder characterized by systemic inflammation and organ dysfunction associated with an increase in pro-inflammatory cytokines.
Czech, Torrey, Mizuno, Hiroki, Momose, Shuji, Nishikori, Asami, Nishimura, Midori Filiz, Nishimura, Yoshito, Ohsawa, Kumiko, Otsuka, Fumio, Otsuka, Yuki, Sato, Yasuharu, Sawa, Naoki, Sawada, Haruki   +11 more
core   +1 more source

A challenging diagnosis of idiopathic multicentric Castleman disease with complex systemic presentation: A case report

Clinical Case Reports, 2023
Key Clinical Message Idiopathic multicentric Castleman disease (iMCD) is challenging to diagnose due to clinical similarities with other conditions, such as Still's disease.
Magdalena Strach, Piotr Kuszmiersz, Łukasz Chmura, Mariusz Korkosz   +3 more
doaj   +1 more source

Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease [PDF]

, 2022
Idiopathic multicentric Castleman disease (iMCD) is a type of Castleman disease that is not related to KSHV/HHV8 infection. Currently, iMCD is classified into iMCD-TAFRO (thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly) and iMCD ...
Maehama, Kanna, Momose, Shuji, Nakamura, Naoya, Nishikori, Asami, Nishimura, Midori Filiz, Nishimura, Yoshito, Ohsawa, Kumiko, Otsuka, Fumio, Sato, Yasuharu   +8 more
core   +2 more sources

Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine

Vaccines, 2022
Idiopathic Multicentric Castleman Disease (iMCD) is a potentially life-threatening systemic disease whose complex symptomatology is due to cytokine dysregulation.
Christian Hoffmann, Thomas Wechselberger, Heinz Drexel, Susanne Dertinger, Stefan Dirnhofer, Sheila K. Pierson, David C. Fajgenbaum, Andreas Kessler   +7 more
doaj   +1 more source